Medical Testing

HAVANA, June 21 (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.

The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. ...

The announcement came from state-run biopharmaceutical corporation BioCubaFarma, which oversees Finlay, the maker of Soberana 2, and the Center for Genetic Engineering and Biotechnology, the producer of Abdala.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Cuba says its Abdala vaccine is 92.28% effective against coronavirus
Log in or register to post comments

GSK-Vir say study confirms its antibody drug reduces hospitalization, death in COVID-19 patients

Mon, 2021-06-21 10:46 — mike kraft

Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients GlaxoSmithKline Plc and Vir Biotechnology said on Monday final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced hospitalization and death among high-risk COVID-19 patients when given early in the disease. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about GSK-Vir say study confirms its antibody drug reduces hospitalization, death in COVID-19 patients
Log in or register to post comments

Gamma and other coronavirus variants, not just Delta, also worry scientists

Mon, 2021-06-21 10:28 — mike kraft

It's not just Delta -- other coronavirus variants worry scientists, also While federal health officials are warning most about the Delta variant -- the B.1.617.2 strain first seen in India -- other variants are also gaining ground in parts of the US. Virginia Langmaid, CNN CNN

(CNN) Coronavirus variants are what keep Dr. Scott Lindquist, an epidemiologist for Washington state, up at night.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Gamma and other coronavirus variants, not just Delta, also worry scientists
Log in or register to post comments

Pfizer BioNTechvaccine shots have stronger antibody response than Sinovac-- Hong Kong study

Sat, 2021-06-19 14:24 — mike kraft

BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows - SCMP People who are vaccinated against COVID-19 with BioNTech's (22UAy.DE) vaccine were found to have "substantially higher" levels of antibodies than those who received Sinovac's jab, the South China Morning Post reported on Saturday, citing a Hong Kong study. Reuters Re

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Pfizer BioNTechvaccine shots have stronger antibody response than Sinovac-- Hong Kong study
Log in or register to post comments

Study into whether digital contact tracing actually worked in the US

Thu, 2021-06-17 21:45 — mike kraft

We investigated whether digital contact tracing actually worked in the US A year ago, engineers built apps to track potential virus exposure. Our research shows the impact has been mixed—but there's still potential. Betsy Ladyzhets MIT Technology Review

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Study into whether digital contact tracing actually worked in the US
Log in or register to post comments

U.S. announces 3 billion dollar program to develop pill to treat Covid-19

Thu, 2021-06-17 11:48 — mike kraft

The U.S. government spent more than $18 billion last year funding drugmakers to make a Covid vaccine, an effort that lead to at least five highly effective shots in record time. Now it’s pouring more than $3 billion on a neglected area of research: developing pills to fight the virus early in the course of infection, potentially saving many lives in the years to come.

Country / Region Tags:

General Topic Tags: